SubHero Banner
Text

Nurtec ODT (rimegepant) – New drug approval

February 27, 2020 - Biohaven Pharmaceuticals announced the FDA approval of Nurtec ODT (rimegepant), for the acute treatment of migraine with or without aura in adults.

Download PDF